Robert S.

Robert S. is an experienced Regulatory Affairs Professional with 20 years in the Pharmaceutical Industry, specializing in areas such as Regulatory Conformance, CMC, and labelling. They have held significant roles at companies like Mylan and GlaxoSmithKline, where they managed teams and implemented key compliance processes. Currently, Robert serves as the Associate Director of Regulatory Affairs at Cycle Pharmaceuticals, overseeing CMC pre- and post-approval strategies and managing regulatory systems. Robert's educational background includes multiple chemistry-related degrees from institutions such as the University of Strasbourg and the University of Surrey.